Early findings from a small clinical trial provide evidence that a new cellular immunotherapy approach may be effective in treating metastatic solid tumors. In the trial, researchers from the National Institutes of Health (NIH) genetically engineered normal white blood cells, known as lymphocytes, from each patient to produce receptors that recognize and attack their specific cancer cells.
The WHO recognizes noma after years of medical-dental disconnect
Fidel Strub was 3 years old when his face began rotting away. “It’s hell. It’s like you have a burning face,” he told me. “You
December 16, 2023